03:18 PM EDT, 05/28/2026 (MT Newswires) -- Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding 1.3%.

The iShares Biotechnology ETF (IBB) climbed 1.5%.

In corporate news, AstraZeneca's ( AZN ) durvalumab, plus Bacillus Calmette-Guerin, received approval by the Food and Drug Administration to treat adults with BCG-naive, high-risk non-muscle invasive bladder cancer, the FDA said Thursday. AstraZeneca ( AZN ) shares rose 0.1%.